These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 10577663)

  • 1. Tenecteplase and alteplase in acute myocardial infarction.
    Norris RM
    Lancet; 1999 Nov; 354(9192):1818-9. PubMed ID: 10577663
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative efficacy of thrombolytics in acute myocardial infarction: a systematic review.
    Dundar Y; Hill R; Dickson R; Walley T
    QJM; 2003 Feb; 96(2):103-13. PubMed ID: 12589008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tenecteplase: new preparation. Another thrombolytic agent for myocardial infarction: a slightly simpler treatment.
    Prescrire Int; 2002 Jun; 11(59):83-4. PubMed ID: 12068843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tenecteplase: a review of its pharmacology and therapeutic efficacy in patients with acute myocardial infarction.
    Dunn CJ; Goa KL
    Am J Cardiovasc Drugs; 2001; 1(1):51-66. PubMed ID: 14728052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of tenecteplase (TNKase) in the treatment of acute myocardial infarction.
    Melandri G; Vagnarelli F; Calabrese D; Semprini F; Nanni S; Branzi A
    Vasc Health Risk Manag; 2009; 5(1):249-56. PubMed ID: 19436656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrinolysis and activators of plasminogen.
    Sobel BE
    Heart Lung; 1987 Nov; 16(6 Pt 2):775-9. PubMed ID: 3119522
    [No Abstract]   [Full Text] [Related]  

  • 7. Tenecteplase for treatment of acute myocardial infarction.
    Turcasso NM; Nappi JM
    Ann Pharmacother; 2001 Oct; 35(10):1233-40. PubMed ID: 11675853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Off-target effects of thrombolytic drugs: apolipoprotein A-I proteolysis by alteplase and tenecteplase.
    Gomaraschi M; Ossoli A; Vitali C; Pozzi S; Vitali Serdoz L; Pitzorno C; Sinagra G; Franceschini G; Calabresi L
    Biochem Pharmacol; 2013 Feb; 85(4):525-30. PubMed ID: 23219857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of tenecteplase in fibrinolytic therapy of acute myocardial infarction.
    Tanswell P; Modi N; Combs D; Danays T
    Clin Pharmacokinet; 2002; 41(15):1229-45. PubMed ID: 12452736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Cannon Ball Bleeds" in the Brain Following Tenecteplase Thrombolysis in Myocardial Infarction.
    Bhatjiwale MG; Bhatjiwale MM; Gadekar S
    Neurol India; 2021; 69(4):1105-1106. PubMed ID: 34507470
    [No Abstract]   [Full Text] [Related]  

  • 11. Safety and efficacy of tenecteplase in acute myocardial infarction.
    Guerra DR; Karha J; Gibson CM
    Expert Opin Pharmacother; 2003 May; 4(5):791-8. PubMed ID: 12740001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tenecteplase: single-bolus thrombolytic therapy for acute myocardial infarction.
    McGahan L
    Issues Emerg Health Technol; 2001 Jan; (13):1-6. PubMed ID: 11902221
    [No Abstract]   [Full Text] [Related]  

  • 13. A review of available fibrin-specific thrombolytic agents used in acute myocardial infarction.
    Tsikouris JP; Tsikouris AP
    Pharmacotherapy; 2001 Feb; 21(2):207-17. PubMed ID: 11213858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial.
    ; Van De Werf F; Adgey J; Ardissino D; Armstrong PW; Aylward P; Barbash G; Betriu A; Binbrek AS; Califf R; Diaz R; Fanebust R; Fox K; Granger C; Heikkilä J; Husted S; Jansky P; Langer A; Lupi E; Maseri A; Meyer J; Mlczoch J; Mocceti D; Myburgh D; Oto A; Paolasso E; Pehrsson K; Seabra-Gomes R; Soares-Piegas L; Sùgrue D; Tendera M; Topol E; Toutouzas P; Vahanian A; Verheugt F; Wallentin L; White H
    Lancet; 1999 Aug; 354(9180):716-22. PubMed ID: 10475182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of tenecteplase in Indian patients with ST-segment elevation myocardial infraction: a future perspetive.
    Tewari S
    Indian Heart J; 2008; 60(6):504-6. PubMed ID: 19276486
    [No Abstract]   [Full Text] [Related]  

  • 16. Early thrombolysis for the treatment of acute myocardial infarction: a systematic review and economic evaluation.
    Boland A; Dundar Y; Bagust A; Haycox A; Hill R; Mujica Mota R; Walley T; Dickson R
    Health Technol Assess; 2003; 7(15):1-136. PubMed ID: 12773258
    [No Abstract]   [Full Text] [Related]  

  • 17. Tenecteplase: a review.
    Davydov L; Cheng JW
    Clin Ther; 2001 Jul; 23(7):982-97; discussion 981. PubMed ID: 11519775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tenecteplase for the treatment of acute ischemic stroke: A review of completed and ongoing randomized controlled trials.
    Coutts SB; Berge E; Campbell BC; Muir KW; Parsons MW
    Int J Stroke; 2018 Dec; 13(9):885-892. PubMed ID: 30035698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tenecteplase in the treatment of acute myocardial infarction.
    Chandra KS; Jariwala P; Lathi P
    Indian Heart J; 2009; 61(5):437-42. PubMed ID: 20635758
    [No Abstract]   [Full Text] [Related]  

  • 20. Tenecteplase: a promising new fibrinolytic agent.
    De Jong MJ; Sabadie-Garretson W
    Dimens Crit Care Nurs; 2001; 20(6):19-23. PubMed ID: 22076580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.